ISMPP is pleased to share information about a publication on Good Practice for Conference Abstracts and Presentations (GPCAP); a publication and presentation related to Good Publication Practice 3 (GPP3) guidelines in the Asia Pacific region; and publications on open access policies of medical journals, medical writing support and clinical trial reporting, and clinical trial transparency commitments by the biopharmaceutical industry.
Good Practice for Conference Abstracts and Presentations (GPCAP) Recommendations Published in Research Integrity and Peer Review
The article titled “Good Practice for Conference Abstracts and Presentations: GPCAP” was published in Research Integrity and Peer Review (RIPR) in June 2019. The GPCAP recommendations address the specific challenges of developing abstracts and presentations for academic conferences. The recommendations cover authorship and contributorship; transparency; development, review, and approval of abstracts and presentations; guidance on re-presentation of data (encore abstracts); copyright considerations; and appropriate citation of conference presentations. The publication authors include current ISMPP members Cate Foster, Jackie Marchington, Mina Patel, and Rianne Stacey. Click here to view the article.
An ISMPP U webinar titled “Good Practice for Conference Abstracts and Presentations” will be held on October 23, 2019, at 11 am EDT/4 pm in the UK.
Applying Good Publication Practice 3 Guidelines in the Asia-Pacific Region Published in Research Integrity and Peer Review
The article titled “A Guide to Applying the Good Publication Practice 3 Guidelines in the Asia-Pacific Region” was published in Research Integrity and Peer Review (RIPR) in October 2019. The article addresses the challenges of interpreting publication recommendations and guidelines, particularly for those individuals for which English is a second language. The article aims to provide a guide for authors and medical publication professionals in the Asia Pacific region on applying GPP3 guidelines and International Committee of Medical Journal Editors (ICMJE) recommendations when developing medical publications. The publication authors include current ISMPP members Blair Hesp, Katsuhisa Arai, Sandeep Kamat, Andrew Sakko, and Hazel Fernandez. Click here to view the article.
An Asia Pacific ISMPP U webinar titled “A Guide to Applying the Good Publication Practice 3 Guidelines in the Asia-Pacific Region” will be held on October 29, 2019, in Asia Pacific countries, and on October 28, 2019, in the US. Information from a preprint of the article was also presented during the recent Asia Pacific Meeting of ISMPP in September 2019.
GPP Guidelines Focus of a Presentation in Asia Pacific Region
Karen Woolley was invited to present on the topic, “What’s So Good about the Good Publication Practice 3 (GPP3) Guidelines and What’s Next?” at the Australasian Medical Writers Association (AMWA) Annual Conference, in August 2019, in Manly Beach, Australia. The presentation covered the GPP3 guidelines and the future of Good Publication Practices, including the forthcoming GPP4 guidelines.
Open Access Policies of Leading Medical Journals Published in BMJ Open
The article titled “Open access policies of leading medical journals: a cross-sectional study” was published in BMJ Open in June 2019. The article reports on a cross-sectional analysis conducted of open access policies of 35 medical journals, with a high impact factor, publishing original research from 13 publishers. The publication authors include current ISMPP members Tim Ellison and Christopher Winchester. Click here to access the publication.
Publications Address Impact of Medical Writing Support on Clinical Trial Reporting, and Clinical Trial Transparency Commitments by the Biopharmaceutical Industry
Two articles addressed the ever-present topics of professional medical writing support and clinical trial reporting, and clinical trial transparency commitments by the biopharmaceutical industry.
- “Professional medical writing support and the quality, ethics and timeliness of clinical trial reporting: a systematic review” was published in Research Integrity and Peer Review (RIPR) in July 2019. The publication authors include current ISMPP members William Gattrell, Richard White, and Christopher Winchester. Click here to access the publication.
- “Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment” was published in BMJ Evidence-Based Medicine in March 2019. The publication authors include current ISMPP members Slavka Baronikova, Julie Beeso, and Christopher Winchester. Click here to access the publication.
Notify Us of Your Publications and Presentations!
ISMPP encourages members to publish and present research/information related to medical publications and scientific communications to advance the professions and improve standards and best practices. Please contact Anna Geraci, ISMPP Director of Communications, at ageraci@ismpp.org, to share your publications and presentations in The MAP.